BNBelakatte P. Nandeshwarappa

Belakatte P. Nandeshwarappa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Belakatte P. Nandeshwarappa has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    RETRACTED: Lokanath et al. Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights. Drugs Drug Candidates 2025, 4, 16

    by Sujatha M. Lokanath, Manjunatha S. Katagi, Girish S. Bolakatti, Johnson Samuel, Belakatte P. Nandeshwarappa

    The journal retracts the article titled “Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights”

  • Synthesis, Characterization, and Biological Activity of Benzothiazole Thioether Derivatives

    by C. Kiran Yadav, B. Manjunatha, B. P. Nandeshwarappa

    Objective: Benzothiazole derivatives linked to coumarin exhibit a broad spectrum of biological activities. Based on this rationale, we synthesized several compounds containing triheterocyclic structures, which are connected via a methine (–CH) group and also feature a biologically relevant thioether bond (–C–S). Methods: We used L-proline as a catalyst in a multicomponent one-pot synthesis. The structures of the synthesized compounds were confirmed by various instrumental techniques, including IR, 1H, 13C NMR, and mass spectrometry. Results and Discussion: The obtained benzothiazole thioether derivatives were screened for antibacterial activity against Eю coli and Sю aureus using the zone of inhibition method. Compounds IVa and IVc exhibited promising antibacterial activity. Conclusions: The synthesized benzothiazole thioether derivatives show potential antibacterial activity, particularly compounds IVa and IVc.

  • Open Access

    RETRACTED: Exploring Chalcone Derivatives as a Multifunctional Therapeutic Agent: Investigating Antioxidant Potential, Acetylcholinesterase Inhibition and Computational Insights

    by Sujatha M. Lokanath, Manjunatha S. Katagi, Girish S. Bolakatti, Johnson Samuel, Belakatte P. Nandeshwarappa

    Background: The cholinergic hypothesis is an elementary approach employed for the research and drug discovery of novel anti-Alzheimer therapeutics. Method: In this context, the study focuses on synthesizing and evaluating a new series of chalcone derivatives (3a–3j) as multifunctional therapeutic agents, specifically investigating their antioxidant potential using the DPPH method with ascorbic acid as a standard. Ellman’s protocol for acetylcholinesterase inhibition assay was performed using donepezil as a standard, and computational insights were explored through molecular docking and ADME profiling. Results: Compounds 3a, 3d, 3e, 3f, and 3h exhibited excellent antioxidant activity compared to the standard. Most of the compounds exhibited moderate to good (3b, 3c, and 3h) AChE inhibitory activity. Molecular docking studies revealed conventional hydrogen bonding and π-π interactions with the enzyme’s active residues, facilitated by their electronegative groups and phenyl rings, respectively. In addition, a pharmacokinetic study was conducted using computational approach to assess druggability. The results demonstrated that compound 3b is an outstanding lead candidate with appreciable AChE inhibitory activity. Conclusions: The combined experimental and computational results of this study highlight the multifunctional nature of chalcone derivatives, suggesting their potential as promising therapeutic agents for the discovery of novel AChE inhibitors that could be employed in the management of Alzheimer’s disease and oxidative stress-related diseases.


  • Design, Synthesis, and Anti-Alzheimer Activity of 2,5-Disubstituted 1,3,4-Thiadiazole: Kinetic Studies, Molecular Docking, and MD Simulations

    by M. L. Sujatha, Prabhu Jalihal, Manjunatha S. Katagi, Durgesh Paresh Bidye, Sheshagiri R. Dixit, B. P. Nandeshwarappa

    Objective: This study aims to design a small library of novel 2,5-disubstituted 1,3,4-thiadiazole derivatives and evaluate their antioxidant and acetylcholinesterase (AChE) inhibitory activities. Methods: A series of 2,5-disubstituted 1,3,4-thiadiazole derivatives were designed, synthesized via a convenient synthetic route, and assessed for their AChE inhibitory activity against electric eel AChE using Ellman’s method. Their antioxidant potential was evaluated via the DPPH free radical scavenging assay. The structures of the synthesized compounds were characterized using FT-IR, 1H, 13C NMR spectroscopy, mass spectrometry, and elemental analysis. Molecular docking and molecular dynamics (MD) simulations were performed to identify potential AChE inhibitors. Results and Discussion: The results demonstrated that compounds (IVe), (IVj), and (IVg) exhibited significant antioxidant activity at 100 µg/mL compared to the reference standard. The AChE inhibition assay revealed that compounds (IVe), (IVj), (IVg), and (IVc) displayed potent inhibitory effects at a concentration of 0.004 M. Kinetic studies elucidated the mode of enzyme inhibition, showing that compound (IVe) exhibited a mixed-type inhibition mechanism, similar to Donepezil. Docking studies predicted moderate to strong binding affinities for all synthesized compounds (IVa–IVj) compared to the reference drug. Among them, compound (IVe) demonstrated the lowest docking energy (–10.549 kcal/mol), suggesting the highest anticholinesterase activity. MD simulations further confirmed the stable binding interactions of compound (IVe) within the active site of AChE. Conclusions: These findings suggest that compound (IVe) is a promising lead structure for the development of novel AChE inhibitors for the treatment of Alzheimer’s disease (AD).


  • Design, Synthesis, and Characterization of Novel 3-(2-Amino-6-arylpyrimidin-4-yl)-1-methylquinolin-2(1H)-one Derivatives and Screening for Their Antioxidant and Acetylcholinesterase Inhibitory Potency

    by M. L. Sujatha, M. S. Katagi, D. K. Ramesh, B. P. Nandeshwarappa

    The cholinergic hypothesis is a fundamental approach employed in the research and discovery of new anti-Alzheimer therapeutics. In this context, a series of 3-[2-amino-6-(substituted phenyl)pyrimidin-4-yl]-1-methylquinolin-2(1H)-one derivatives 4a–4j were synthesized by condensing guanidine with 1-methyl-3-[(E)-3-oxo-3-(substituted phenyl)prop-1-en-1-yl)quinolin-2(1H)-ones 3a–3j which were prepared by condens­ing 1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde (1) with various substituted acetophenones 2a–2j. The structures of the synthesized compounds were confirmed by elemental analysis, 1H and 13C NMR, IR, and mass spectrometry. Compounds 4a–4j were evaluated for their antioxidant activity using the DPPH method and for acetylcholinesterase inhibition by Ellman’s assay. Compounds 4c, 4e, 4g, and 4j exhibited excellent antioxidant activity compared to the standard (ascorbic acid). Most of the compounds showed moderate to good (4a, 4c, 4f, and 4g) AChE inhibitory activity. The results demonstrated that compound 4c with strong AChE inhibitory activity is promising for further investigation aimed at discovering novel AChE inhibitors that could be employed in the management of Alzheimer’s disease.

  • Synthesis, Characterization, and Biological Studies of Novel 4-Hydroxy-6-methyl-5,6-dihydro-2H-pyran-2-one Based Azo Dyes

    by C. Kiran Yadav, B. Manjunatha, B. P. Nandeshwarappa

    Objective: Due to wide range of biological activities exhibited by pyran derivatives such as antibacterial, antioxidant, anticancer and other activities, we have synthesized and investigated the biological activity of some pyran derivatives. Methods: A series of 4-hydroxy-6-methyl-5,6-dihydro-2H-pyran-2-one based azo dyes (IIIa–IIIf) have been synthesized by a conventional diazo coupling reaction. The antioxidant activity was determined via DPPH assay and Antimicrobial activity through disc diffusion test. Results and Discussion: Compound (IIIb) has shown excellent radical scavenging activity with an IC50 value of 20.22 ± 7.36 µg/mL compared to the standard. Furthermore, compounds (IIIc) and (IIId) showed a good antibacterial and antifungal activity against Escherichia coli and Aspergillus niger compared to other prepared azo compounds. Conclusions: We propose that in future, synthesized compounds may act as a promising antimicrobial drugs.

  • Synthesis and Characterization of Substituted 5-(2-Chloroquinolin-3-yl)-1,3,4-oxadiazole-2-amines: Computational, In Silico ADME, Molecular Docking, and Biological Activities

    by H. Maruthesh, Manjunatha S. Katagi, Johnson Samuel, Ravindranath H. Aladakatti, B. P. Nandeshwarappa

    A series of 5-(2-chloroquinolin-3-yl)-1,3,4-oxadiazole-2-amine (IIIa–IIIj) with different biological activities were designed and synthesized through the cyclization of semicarbazone. All the newly synthesized compounds were characterized by elemental analysis, 1H NMR, 13C NMR, FT-IR, and mass spectrometry. All the newly synthesized final compounds (IIIa–IIIj) were screened for in vitro antimicrobial activity by diffusion into agar wells using Gentamicin as the antibacterial agent and Fluconazole as the antifungal control. In addition, selected compounds were screened for antitubercular activity using Microplate Alamar Blue Assay (MABA). All the compounds were evaluated computationally for drug similarity using various pharmacokinetic studies and ADME-T characterization, then tested in vitro against Gram+ bacteria (Staphylococcus aureus and Bacillus subtilis), Gram– bacteria (S. typhi and P. aeruginosa), fungi (Aspergillus niger and Fusarium), as well as the Mycobacterium tuberculosis H37Rv strain, provided important information about activity against these strains. In the current study, we have discussed the method for the synthesis of 1,3,4-oxadiazole derivatives and summarized the role of compounds (IIIa), (IIIb), (IIId), (IIIg), (IIIh), and (IIIi) as potential antibacterial and antitubercular agents. We put forward further in vivo evaluation and biological activity evaluation for their use against these pathogens.


  • Design, Synthesis, and Computational Characterization of Interesting Schiff Base Scaffolds as Antibacterial, Antimycobacterial, and Antifungal Agents

    by H. Maruthesh, M. S. Katagi, J. Samuel, B. P. Nandeshwarappa

    A series of (E)-1-(3/4-{[(E)-(2-chloroquinolin-3-yl)methylidene]amino}phenyl)ethan-1-one oximes 3a–3j have been designed and synthesized by the condensation of 2-chloroquinoline-3-carbaldehydes and (E)-1-(3/4-aminophenyl)ethan-1-one oximes using glacial acetic acid as a catalyst. The structures of the newly synthesized compounds were characterized by 1H and 13C NMR, FT-IR, and mass spectra. All compounds 3a–3j were assessed for their drug likeness and ADMET properties using computational analysis. They showed optimal drug scores and negligible toxicities and satisfied Lipinskiʼs rule of five. Compounds 3f, 3h, and 3i exhibited significant antimicrobial activity against Gram-positive (S. aureus, B. subtilis) and Gram-negative bacteria (S. Typhi, P. aeruginosa) and fungi (A. niger, A. flavus), whereas compounds 3g–3j showed antimyco­bacterial activity against Mycobacterium tuberculosis H37Rv strain with MIC in the range of 1.6 to 100 µg/mL.


  • A Versatile Approach for the Synthesis, Characterization, and Bioassay of Novel 3-(1-Acetyl-5-substituted phenyl-4, 5-dihydro-1H-pyrazol-3-yl)-4-hydroxy-1-methyl/phenylquinolin-2(1H)-one Derivatives

    by H. Maruthesh, Manjunatha S. Katagi, B. P. Nandeshwarappa

    A series of novel 3-(1-acetyl-5-substitutedphenyl-1H-pyrazol-3-yl)-4-hydroxy-1-methylquinolin-2(1H)-ones (Va–Vf) and 3-(1-acetyl-5-substitutedphenyl-1H-pyrazol-3-yl)-4-hydroxy-1-phenylquinolin-2(1H)-ones (Vg–Vl) were designed and synthesized by the condensation of hydrazine hydrate with (E)-3-(3-(substituted phenyl)acryloyl)-4-hydroxy-1-methyllquinolin-2(1H)-one (IVa–IVf) and (E)-3-(3-(substituted phenyl)acryloyl)-4-hydroxy-1-phenylquinolin-2(1H)-one (IVg–IVl) and these intermediates are prepared from 3-acetyl-4-hydroxy-1-methylquinolin-2(1H)-one (Ia) and 3-acetyl-4-hydroxy-1-phenylquinolin-2(1H)-one (IIa) with diversely functionalized aldehydes (IIIa–IIIf). This synthetic approach provides a new and efficient tool for constructing novel heterocycles on newly synthesized substituted α,β-unsaturated carbonyl compounds. The structures of all the synthesized products were confirmed with their elemental analysis, 1H NMR, 13C NMR, IR, and MS analysis. Further, the newly synthesized compounds were screened for in vitro antibacterial activity against G+ bacteria (S. aureus and B. subtili), G– bacteria (P. aeruginosa and C. albicans), antifungal activity against (C. albicans and A. niger) by using agar well diffusion method. Ciprofloxacin was used as a standard reference drug for antibacterial and Fluconazole drug was used for antifungal activity. The study reveals that the compounds (Ve), (Vf), (Vi), (Vk), and (Vl) showed potential activity against G+ bacteria, and compounds (Vc), (Ve), (Vi), (Vk), and (Vl) showed significant activity against G– bacteria. Compounds (Va), (Vc), (Ve), (Vf), (Vh), (Vi), (Vk), and (Vl) exhibited excellent potential against the antifungal activity.


  • Benzothiazole‐Hydrazone Chromophores: Synthesis, Solvatochromism, Computational and Antimycobacterial Activity Studies

    by Kiran Yadav C, Manjunatha Basavaraju, Kuntewale Mohiyouddin Mussuvir Pasha, Johnson Samuel, Belakatte P Nandeshwarappa

    Coumarin and its heterocyclic derivatives have been receiving tremendous attention from synthetic and medicinal chemists owing to their remarkable application in material science as well as pharmacological applications. In the current study, a series of coumarin‐coupled benzothiazole hydrazone compounds were synthesized by a two‐step process, post which their structural features were investigated with the aid of various spectroscopic techniques. The novel synthesized chromophores displayed an electronic absorption band in a range of 358–428 nm and exhibited a positive solvatochromism character as well as a high molar absorption coefficient in the studied solvents. HOMO‐LUMO gap, quantum parameters, and various other pharmacokinetics and ADME‐T properties of these compounds were investigated through the computational approach. Biological activity assays revealed that all compounds displayed excellent antibacterial activity compared to the Amoxicillin and have also been studied for their antimycobacterial efficacy against Mycobacterium tuberculosis . Furthermore, molecular docking studies was performed with enoyl‐acyl carrier protein reductase (InhA).